UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LPRO
5076
DELISTED
Open Lending Corp
LPRO
| $443K | ﹤0.01% |
79,415
-42,785
| -35% | -$246K |
|
5077
Vanda Pharmaceuticals
VNDA
$302M
| $443K | ﹤0.01% |
78,410
+12,012
| +18% | +$62K |
|
|
FFWM
5078
DELISTED
First Foundation Inc
FFWM
| $443K | ﹤0.01% |
67,602
+2,223
| +3% | +$13.6K |
|
|
GOOS
5079
Canada Goose Holdings
GOOS
$856M
| $441K | ﹤0.01% |
34,100
-6,328
| -16% | -$78.6K |
|
5080
CALL
ResMed
RMD
$30.7B
| $440K | ﹤0.01% |
2,300
-30,755
| -93% | -$6.24M |
|
5081
Repay Holdings
RPAY
$327M
| $440K | ﹤0.01% |
41,660
-57,397
| -58% | -$587K |
|
|
NAPA
5082
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $440K | ﹤0.01% |
61,943
-162,924
| -72% | -$1.31M |
|
5083
Perella Weinberg Partners
PWP
$1.3B
| $439K | ﹤0.01% |
27,003
-40,119
| -60% | -$606K |
|
5084
Zentalis Pharmaceuticals
ZNTL
$302M
| $438K | ﹤0.01% |
107,100
-160,765
| -60% | -$1.8M |
|
|
TELL
5085
DELISTED
Tellurian Inc.
TELL
| $438K | ﹤0.01% |
631,948
-1,578,383
| -71% | -$874K |
|
|
CCRV
5086
DELISTED
iShares Commodity Curve Carry Strategy ETF
CCRV
| $436K | ﹤0.01% |
+20,106
| New | +$434K |
|
|
ITOS
5087
DELISTED
iTeos Therapeutics
ITOS
| $436K | ﹤0.01% |
29,386
-29,708
| -50% | -$426K |
|
5088
Weis Markets
WMK
$1.86B
| $436K | ﹤0.01% |
6,946
-20,902
| -75% | -$1.33M |
|
5089
Willdan Group
WLDN
$1.3B
| $436K | ﹤0.01% |
15,108
-3,340
| -18% | -$99.6K |
|
5090
Lifestance Health
LFST
$4.14B
| $436K | ﹤0.01% |
88,754
-16,636
| -16% | -$100K |
|
|
PDS
5091
Precision Drilling
PDS
$974M
| $436K | ﹤0.01% |
6,193
-2,370
| -28% | -$167K |
|
5092
LendingTree
TREE
$451M
| $435K | ﹤0.01% |
10,470
-500
| -5% | -$21.1K |
|
5093
Global X Emerging Markets ex-China ETF
EMM
$55.7M
| $435K | ﹤0.01% |
15,274
+3,806
| +33% | +$104K |
|
5094
Mercantile Bank Corp
MBWM
$1.05B
| $435K | ﹤0.01% |
10,728
-8,130
| -43% | -$304K |
|
5095
Invesco S&P 500 BuyWrite ETF
PBP
$362M
| $435K | ﹤0.01% |
19,636
+2,443
| +14% | +$54.2K |
|
5096
Invesco S&P SmallCap 600 Pure Growth ETF
RZG
$139M
| $434K | ﹤0.01% |
9,151
-1,930
| -17% | -$91.3K |
|
5097
Palmer Square Capital BDC
PSBD
$320M
| $434K | ﹤0.01% |
26,842
+16,543
| +161% | +$272K |
|
5098
ARKO Corp
ARKO
$635M
| $434K | ﹤0.01% |
69,165
-21,389
| -24% | -$115K |
|
|
MVT
5099
DELISTED
BlackRock MuniVest Fund II
MVT
| $434K | ﹤0.01% |
39,243
+18,395
| +88% | +$196K |
|
5100
Invesco ESG NASDAQ 100 ETF
QQMG
$204M
| $432K | ﹤0.01% |
+13,044
| New | +$403K |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.